Diagnostics Regulation Provisions Not In Second Cures Draft

House lawmakers diverged from their earlier plan to update regulations surrounding diagnostics, with the second draft of their Cures bill instead directing FDA to clarify when test-makers can seek waivers exempting their products from certain laboratory requirements. Lawmakers had put a diagnostics "placeholder" in the first draft of the Cures bill intended to be filled in if stakeholders could forge a consensus on the hot-button regulatory issue. The second draft of the bill , unveiled by the House Energy and...